Genelux (GNLX) Common Equity (2022 - 2026)

Genelux's Common Equity history runs 5 years deep, the most recent figure standing at $22.9 million for Q1 2026.

• On a quarterly basis, Common Equity fell 23.2% year-over-year to $22.9 million in Q1 2026; TTM through Mar 2026 was $22.9 million, a 23.2% decrease from a year earlier, with the FY2025 full-year figure at $11.5 million, down 56.06% from the prior year.
• Common Equity improved to $22.9 million in Q1 2026 per GNLX's latest filing, from $11.5 million in the prior quarter.
• Across five years, Common Equity topped out at $37.7 million in Q2 2024 and bottomed at -$35.8 million in Q4 2022.
• The 5-year median for Common Equity is $22.3 million (2023), against an average of $14.6 million.
• Across the five-year window, Common Equity soared 460.54% in 2024 and tumbled 56.06% in 2025, its largest moves.
• Year by year, Common Equity stood at -$35.8 million in 2022, then jumped by 154.42% to $19.5 million in 2023, then jumped by 34.93% to $26.3 million in 2024, then tumbled by 56.06% to $11.5 million in 2025, then soared by 98.55% to $22.9 million in 2026.
• Per Business Quant, the three latest GNLX Common Equity figures stand at $22.9 million (Q1 2026), $11.5 million (Q4 2025), and $18.6 million (Q3 2025).